Syngene sets up R&D centre for Amgen in Bengaluru

By: |
New Delhi | Updated: September 07, 2016 1:33 PM

Biocon's contract research arm Syngene International has established an integrated, multi-disciplinary drug discovery and development centre for Amgen in Bengaluru.

"Bringing together into one place, the range of activities we conduct on behalf of Amgen indicates the strategic nature of our relationship and also reflects the ability of Syngene's scientific teams to deliver world-class science towards our partners' R&D programmes in both biotechnology and small molecule medicines," Syngene International CEO Jonathan Hunt said.“Bringing together into one place, the range of activities we conduct on behalf of Amgen indicates the strategic nature of our relationship and also reflects the ability of Syngene’s scientific teams to deliver world-class science towards our partners’ R&D programmes in both biotechnology and small molecule medicines,” Syngene International CEO Jonathan Hunt said.

Biocon’s contract research arm Syngene International has established an integrated, multi-disciplinary drug discovery and development centre for Amgen in Bengaluru.

The centre, named Syngene Amgen Research and Development Center (SARC), will be Syngene’s fourth such exclusive R&D unit, the company said in a filing to BSE.

It, however, did not disclose the cost of establishing the centre.

The company already operates dedicated R&D centres for Bristol-Myers Squibb, Abbott Nutrition and Baxter, Syngene International said.

“Bringing together into one place, the range of activities we conduct on behalf of Amgen indicates the strategic nature of our relationship and also reflects the ability of Syngene’s scientific teams to deliver world-class science towards our partners’ R&D programmes in both biotechnology and small molecule medicines,” Syngene International CEO Jonathan Hunt said.

With the establishment of SARC, the association of the company and Amgen now extends into a collaboration spanning capabilities in medicinal and process chemistry, biologics, bioprocess, drug metabolism, pharmacokinetics, bioanalytical research, and pharmaceutical development, Syngene said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Cipla inks pact with Eli Lilly to produce, sell COVID-19 treatment drug
2L&T donates 24 ventilators to hospitals in south Gujarat
3Fintechs pick up MDR tab, enjoy merchant’s float